Lorenz Trümper

Active 1994–2025

77
Papers
20,355
Citations
62
h-index
75
i10-index

Citations

Citations per year for Lorenz Trümper1974: 1 citations1979: 1 citations1994: 1 citations1995: 7 citations1996: 7 citations1997: 6 citations1998: 7 citations1999: 5 citations2000: 12 citations2001: 10 citations2002: 26 citations2003: 31 citations2004: 22 citations2005: 40 citations2006: 50 citations2007: 71 citations2008: 130 citations2009: 128 citations2010: 154 citations2011: 205 citations2012: 200 citations2013: 153 citations2014: 173 citations2015: 164 citations2016: 153 citations2017: 146 citations2018: 147 citations2019: 581 citations2020: 658 citations2021: 633 citations2022: 495 citations2023: 322 citations2024: 542 citations2025: 209 citations2026: 5 citations1975–1978: no citations, so these years are not shown1980–1993: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,885 citing papers, 22.6% of this breakdownGermany: 857 citing papers, 10.3% of this breakdownChina: 621 citing papers, 7.4% of this breakdownUnited Kingdom: 495 citing papers, 5.9% of this breakdownItaly: 488 citing papers, 5.8% of this breakdownFrance: 429 citing papers, 5.1% of this breakdownSpain: 347 citing papers, 4.2% of this breakdownCanada: 341 citing papers, 4.1% of this breakdownSwitzerland: 275 citing papers, 3.3% of this breakdownNetherlands: 235 citing papers, 2.8% of this breakdownJapan: 213 citing papers, 2.5% of this breakdownAustralia: 189 citing papers, 2.3% of this breakdown
0%22.6%Other 23.7%

Fields

  • Medicine70.6%
  • Biochemistry, Genetics and Molecular Biology23%
  • Immunology and Microbiology3.7%
  • Neuroscience1.6%
  • Pharmacology, Toxicology and Pharmaceutics0.2%
  • Materials Science0.2%
  • Other0.7%

Topics

  • Lymphoma Diagnosis and Treatment17.3%
  • Chronic Lymphocytic Leukemia Research6%
  • CAR-T cell therapy research5%
  • Viral-associated cancers and disorders4.4%
  • CNS Lymphoma Diagnosis and Treatment4.2%
  • Immune Cell Function and Interaction2.5%
  • Other60.6%

Coauthors

All papers

Open in search
  1. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Reiner Siebert, Andreas Rosenwald, Aaron R. Thorner, Matthew Meyerson, Todd R. Golub, Rameen Beroukhim, Gerald Wulf, German Ott, Scott J. Rodig, Stefano Monti, Donna Neuberg, Markus Loeffler, Michael Pfreundschuh, Lorenz Trümper, Gad Getz, Margaret A. Shipp - Nature Medicine 2018 cited by 1,972

  2. The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2021 cited by 262

  3. Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lorenz Trümper, David M. Aboulafia, Ranjana H. Advani, Önder Alpdoğan, Kiyoshi Ando, Luca Arcaini, Luca Baldini, Naresh Bellam, Nancy L. Bartlett, David Belada, Dina Ben Yehuda, Fabio Benedetti, Peter Borchman, Dominique Bordessoule, Pauline Brice, Javier Briones, Dolores Caballero, Angelo Michele Carella, Hung Chang, June Weon Cheong, Seok‐Goo Cho, Ilseung Choi, Sylvain Choquet, Andrei Coliţă, Angela Giovanna Congui, Francesco d’Amore, Nam H. Dang, Kelly Davison, Sophie de Guibert, Peter de Nully Brown, Vincent Delwail, Judit Demeter, Francesco Di Raimondo, Young Rok, Eva Domingo, Michael G. Douvas, Martin Dreyling, Thomas Ernst, Michelle A. Fanale, Keith Fay, Tatyana Feldman, Silvia Ferrero, Ian W. Flinn, Andres Forero‐Torres, Christopher P. Fox, Jonathan W. Friedberg, Noriko Fukuhara, José A. García‐Marco, Jorge Gayoso Cruz, José Codina, Rémy Gressin, Andrew Grigg, Ronit Gurion, Jacob Haaber Christensen, Corinne Haïoun, Roman Hájek, Mathias Hänel, Kiyohiko Hatake, Robert Hensen, Netanel A. Horowitz, Steven M. Horwitz, Andreas Hüttmann, Árpád Illés, Tim Illidge, Kenichi Ishizawa, Miguel Islas‐Ohlmayer, Eric D. Jacobsen, Murali Janakiram, Wojciech Jurczak, Mark Kaminski and 69 more - The Lancet 2018 cited by 726

  4. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2006 cited by 2,085

  5. CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group

    Authors: , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2011 cited by 811

  6. Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2008 cited by 1,135

  7. Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christiane Falge, Lothar Kanz, Stephan Kremers, Andreas Burchert, Michael Kneba, Frank Stegelmann, Claus-Henning Köhne, H. W. Lindemann, Cornelius F. Waller, M. Pfreundschuh, Karsten Spiekermann, Wolfgang E. Berdel, Lothar Müller, Matthias Edinger, Jiřı́ Mayer, Dietrich W. Beelen, Martin Bentz, Hartmut Link, Bernd Hertenstein, Roland J. Fuchs, Martin Wernli, Frank Schlegel, Rudolf Schlag, Maike de Wit, Lorenz Trümper, Holger Hebart, Markus Hahn, Jörg Thomalla, Christof Scheid, Philippe Schafhausen, Walter Verbeek, Michael J. Eckart, W. Gaßmann, Antonio Pezzutto, Michael Schenk, Peter Brossart, Thomas Geer, Stephan Bildat, E. Schäfer, Andreas Hochhaus, Joerg Hasford - Leukemia 2017 cited by 339

  8. The genomic and transcriptional landscape of primary central nervous system lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lorenz Trümper, Ioannis Anagnostopoulos, Dido Lenze, Ralf Küppers, Michael Hummel, Clemens A. Schmitt, Otmar D. Wiestler, Stephan Wolf, Andreas Unterberg, Roland Eils, Christel Herold‐Mende, Benedikt Brors, Coordination (C1), Reiner Siebert, Susanne Wagner, Andrea Haake, Julia Richter, Gesine Richter, Roland Eils, Chris Lawerenz, Jürgen Eils, Jules N. A. Kerssemakers, Christina Jaeger-Schmidt, Ingrid Scholz, Anke Bergmann, Christoph Borst, Friederike Braulke, Birgit Burkhardt, Alexander Claviez, Martin Dreyling, Sonja Eberth, Hermann Einsele, Norbert Frickhofen, Siegfried Haas, Martin‐Leo Hansmann, Dennis Karsch, Nicole Klepl, Michael Kneba, Jasmin Lisfeld, Luisa Mantovani‐Löffler, Marius Rohde, German Ott, Christina Stadler, Peter Staib, Stephan Stilgenbauer, Thorsten Zenz, Normal Cells (WPN), Martin‐Leo Hansmann, Dieter Kube, Pathology and Analyte Preparation (WP2-3), Siegfried Haas, Wolfgang Hiddemann, Ulrike Kostezka, Peter Möller, Andreas Rosenwald, German Ott, Monika Szczepanowski, Sequencing and genomics (WP4-7), Ole Ammerpohl, Sietse Aukema, Vera Binder, Arndt Borkhardt, Andrea Haake, Jessica I. Hoell, Ellen Leich, Peter Lichter, Cristina López, Inga Nagel, Jordan Pischimariov, Bernhard Radlwimmer and 27 more - Nature Communications 2022 cited by 140

  9. Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2010 cited by 921

  10. Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group

    Authors: , , , , , , , , , - Blood 2010 cited by 592

  11. Exosomal evasion of humoral immunotherapy in aggressive B-cell lymphoma modulated by ATP-binding cassette transporter A3

    Authors: , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2011 cited by 359

  12. NAD(P)H Oxidase and Multidrug Resistance Protein Genetic Polymorphisms Are Associated With Doxorubicin-Induced Cardiotoxicity

    Authors: , , , , , , , , , , , , , , , , , , , , - Circulation 2005 cited by 488

  13. Randomized Phase III Study of Alisertib or Investigator’s Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 cited by 150

  14. Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael Hummel, Jan O. Korbel, Chris Lawerenz, Dido Lenze, Bernhard Radlwimmer, Julia Richter, Philip Rosenstiel, Andreas Rosenwald, Markus B. Schilhabel, Harald Stein, Stephan Stilgenbauer, Peter F. Stadler, Monika Szczepanowski, Marc A. Weniger, Marc Zapatka, Roland Eils, Peter Lichter, Markus Loeffler, Peter Mӧller, Lorenz Trümper, Wolfgang Hiddemann, Susanne Wagner, Gesine Richter, Jürgen Eils, Jules N. A. Kerssemakers, Christina Jaeger-Schmidt, Ingrid Scholz, Christoph Borst, Friederike Braulke, Martin Dreyling, Sonja Eberth, Hermann Einsele, Norbert Frickhofen, Siegfried Haas, Dennis Karsch, Nicole Klepl, Michael Kneba, Jasmin Lisfeld, Luisa Mantovani‐Löffler, German Ott, Christina Stadler, Peter Staib, Thorsten Zenz, Dieter Kube, Ulrike Kostezka, Vera Binder, Ellen Leich, Inga Nagel, Jordan Pischimariov, Stefan Schreiber, Inga Vater, Lydia Hopp, David Langenberger, Maciej Rosołowski, Steve Hoffmann, Ralf Küppers, Birgit Burkhardt, Matthias Schlesner, Reiner Siebert - Nature Communications 2019 cited by 154

  15. A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rainer Spang, Markus Loeffler, Lorenz Trümper, Harald Stein, Reiner Siebert - New England Journal of Medicine 2006 cited by 1,009

  16. Microglia promote colonization of brain tissue by breast cancer cells in a Wnt‐dependent way

    Authors: , , , , , , , , , , , , , , , , - Glia 2010 cited by 244

  17. A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lorenz Trümper, Inga Vater, Swen Weßendorf, Wolfgang Hiddemann, Reiner Siebert - Blood 2014 cited by 228

  18. Clinical Impact of the Cell-of-Origin Classification and the MYC / BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 cited by 219

  19. DNA methylome analysis in Burkitt and follicular lymphomas identifies differentially methylated regions linked to somatic mutation and transcriptional control

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dennis Karsch, Hinrik H D Kerstens, Wolfgang Hiddemann, Markus Kreuz, Chris Lawerenz, Dido Lenze, Markus Loeffler, Cristina López, Roderick A.F. MacLeod, Joost H.A. Martens, Marta Kulis, José I. Martín‐Subero, Peter Mӧller, Inga Nagel, Simone Picelli, Inga Vater, Marius Rohde, Philip Rosenstiel, Maciej Rosołowski, Robert B. Russell, Markus B. Schilhabel, Matthias Schlesner, Peter F. Stadler, Monika Szczepanowski, Lorenz Trümper, Hendrik G. Stunnenberg, Ralf Küppers, Ole Ammerpohl, Peter Lichter, Reiner Siebert, Steve Hoffmann, Bernhard Radlwimmer - Nature Genetics 2015 cited by 150

  20. Mutational mechanisms shaping the coding and noncoding genome of germinal center derived B-cell lymphomas

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Volker Hovestadt, Bingding Huang, Michael Hummel, Christina Jäger-Schmidt, Jules N. A. Kerssemakers, Jan O. Korbel, Dieter Kube, Chris Lawerenz, Dido Lenze, Joost H.A. Martens, German Ott, Bernhard Radlwimmer, Eva Reisinger, Julia Richter, Daniel Rico, Philip Rosenstiel, Andreas Rosenwald, M. Schillhabel, Stephan Stilgenbauer, Peter F. Stadler, José I. Martín‐Subero, Monika Szczepanowski, Gregor Warsow, Marc A. Weniger, Marc Zapatka, Alfonso Valencia, Hendrik G. Stunnenberg, Peter Lichter, Peter Mӧller, Markus Loeffler, Roland Eils, Wolfgang Hiddemann, Steve Hoffmann, Lorenz Trümper, Ralf Küppers, Matthias Schlesner, Reiner Siebert - Leukemia 2021 cited by 59

  21. Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Leukemia 2020 cited by 91

  22. New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients

    Authors: , , , , , , , , , , , , , , , , , , - Blood 2007 cited by 789

  23. Wnt 5a signaling is critical for macrophage-induced invasion of breast cancer cell lines

    Authors: , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2006 cited by 366

  24. MYC/MIZ1-dependent gene repression inversely coordinates the circadian clock with cell cycle and proliferation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Martin Dreyling, Sonja Eberth, Lorenz Trümper, Dieter Kube, Christina Stadler, Hermann Einsele, Norbert Frickhofen, Martin‐Leo Hansmann, Dennis Karsch, Michael Kneba, Luisa Mantovani‐Löffler, Peter Staib, Stephan Stilgenbauer, German Ott, Ralf Küppers, Marc A. Weniger, Michael Hummel, Dido Lenze, Monika Szczepanowski, Wolfgang Hiddemann, Ulrike Kostezka, Peter Möller, Andreas Rosenwald, Ellen Leich, Jordan Pischimariov, Vera Binder, Arndt Borkhardt, Kebria Hezaveh, Jessica I. Hoell, Philip Rosenstiel, Markus B. Schilhabel, Stefan Schreiber, Stephan H. Bernhart, Gero Doose, Steve Hoffmann, Helene Kretzmer, David Langenberger, Hans Binder, Lydia Hopp, Markus Kreuz, Markus Loeffler, Maciej Rosołowski, Jan O. Korbel, Stefanie Sungalee, Peter F. Stadler, Thorsten Zenz, Roland Eils, Matthias Schlesner, Axel Diernfellner, Michael Brunner - Nature Communications 2016 cited by 125